Response of metastatic glioma to vemurafenib

KE Leaver, N Zhang, JL Ziskin, H Vogel… - Neuro-Oncology …, 2016 - academic.oup.com
Extraneural metastatic disease of glioma is rare and poses unique therapeutic challenges.
Increasingly, the ability to sequence genetic alterations in tumors has allowed for the …

[HTML][HTML] Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF …

DG Roller, B Capaldo, S Bekiranov, AJ Mackey… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Over half of BRAFV600E melanomas display intrinsic resistance to BRAF inhibitors, in part
due to adaptive signaling responses. In this communication we ask whether BRAFV600E …

2b or not 2b: how opposing FGF receptor splice variants are blocking progress in precision oncology

RJ Epstein, LJ Tian, YF Gu - Journal of Oncology, 2021 - Wiley Online Library
More than ten thousand peer‐reviewed studies have assessed the role of fibroblast growth
factors (FGFs) and their receptors (FGFRs) in cancer, but few patients have yet benefited …

Targeting CD44 and other pleiotropic co-receptors as a means for broad inhibition of tumor growth and metastasis

LM Mehner, L Munoz-Sagredo, SJ Sonnentag… - Clinical & Experimental …, 2024 - Springer
Although progress has been made in the treatment of cancer, particularly for the four major
types of cancers affecting the lungs, colon, breast and prostate, resistance to cancer …

Preclinical evidence for the use of sunitinib malate in the treatment of plexiform neurofibromas

MJ Ferguson, SD Rhodes, L Jiang, X Li… - Pediatric blood & …, 2016 - Wiley Online Library
Purpose Plexiform neurofibromas (pNF) are pathognomonic nerve and soft tissue tumors of
neurofibromatosis type I (NF1), which are highly resistant to conventional chemotherapy and …

Antiproliferative effects of formononetin on human colorectal cancer via suppressing cell growth in vitro and in vivo

J Huang, M Xie, P Gao, Y Ye, Y Liu, Y Zhao, W Luo… - Process …, 2015 - Elsevier
Formononetin (FT) is a natural phytoestrogen isolated from red clover (Trifolium pratense L.).
Growing evidences indicate that FT-mediated cell arrest in cancers in vitro. However …

MULTITARGETED POLYPHARMACOTHERAPY for CANCER TREATMENT. THEORETICAL CONCEPTS and PROPOSALS.

A Duenas-Gonzalez, A Gonzalez-Fierro… - Expert Review of …, 2024 - Taylor & Francis
Introduction. The pharmacological treatment of cancer has evolved from cytotoxic to
molecular targeted therapy. The median survival gains of 124 drugs approved by the FDA …

Atractylenolide II Suppresses Glycolysis and Induces Apoptosis by Blocking the PADI3-ERK Signaling Pathway in Endometrial Cancer Cells

S Tian, L Ren, C Liu, Z Wang - Molecules, 2024 - mdpi.com
Atractylenolide II (AT-II), the major bioactive compound of Atractylodes macrocephala,
exhibits anti-cancer activity against many types of tumors, but the roles and the potential …

Prognostic gene signature for squamous cell carcinoma with a higher risk for treatment failure and accelerated MEK-ERK pathway activity

B Feng, K Wang, E Herpel, M Plath, W Weichert… - Cancers, 2021 - mdpi.com
Simple Summary Squamous cell carcinoma (SCC) is the most prevalent type of human
cancer worldwide and represents the majority of head and neck tumors. As SCC from …

miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a review

H Kouchaki, P Kamyab, F Darbeheshti… - Journal of the Egyptian …, 2024 - Springer
Abstract Background MicroRNAs (miRNAs or miRs) are highly conserved non-coding RNAs
with a short length (18–24 nucleotides) that directly bind to a complementary sequence …